RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Eosinophilic Granulomatosis with Polyangiitis: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
When Eosinophilic Granulomatosis With Polyangiitis (EGPA) Looks Like Granulomatosis With Polyangiitis (GPA): Navigating a Complex Case of Anti-neutrophil Cytoplasmic Antibodies (ANCA) Vasculitis
Kontor M et al. (16 October 2026)
https://europepmc.org/search?query=When%20Eosinophilic%20Granulomatosis%20With%20Polyangiitis
- 2.
Benralizumab achieves sustained remission and glucocorticoid sparing in patients with eosinophilic granulomatosis with polyangiitis and asthma: a Spanish multicentre real-world cohort study
A. Padilla-Galo et al., Respiratory Research (15 October 2026)
https://doi.org/10.1186/s12931-026-03946-2
- 3.
Clinical experience with anti-interleukin-5 monoclonal antibodies in the treatment of eosinophilic granulomatosis with polyangiitis.
Arribas Elena Benito et al., Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42875351/
- 4.
Multiple cranial neuropathies in a patient with eosinophilic granulomatosis with polyangiitis.
Guzman Duran Daniela Nicol et al., BMJ case reports (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42869571/
- 5.
Allergic profile and pre-diagnostic exposure to allergen-specific immunotherapy in eosinophilic granulomatosis with polyangiitis (EGPA): a single-centre retrospective observational study.
Moroni Luca et al., Clinical rheumatology (12 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42862272/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Eosinophilic Granulomatosis with Polyangiitis
Eosinophilic Granulomatosis with Polyangiitis is a rare ANCA-associated systemic vasculitis characterised by severe asthma, eosinophilia, and small-vessel inflammation affecting multiple organs. The recent approval of mepolizumab (an anti-IL-5 antibody) has transformed treatment, enabling steroid reduction. Cardiac involvement is a key predictor of mortality.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Eosinophilic Granulomatosis with Polyangiitis?
Eosinophilic Granulomatosis with Polyangiitis is a rare ANCA-associated systemic vasculitis characterised by severe asthma, eosinophilia, and small-vessel inflammation affecting multiple organs. The recent approval of mepolizumab (an anti-IL-5 antibody) has transformed treatment, enabling steroid reduction. Cardiac involvement is a key predictor of mortality.
How many clinical trials are available for Eosinophilic Granulomatosis with Polyangiitis?
RareWays currently indexes 27 clinical trials for Eosinophilic Granulomatosis with Polyangiitis, of which 5 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Eosinophilic Granulomatosis with Polyangiitis come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Eosinophilic Granulomatosis with Polyangiitis.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.